During his keynote at Cerner Health Conference (CHC), the company's Chairman and CEO, Brent Shafer, unveiled a next-generation cognitive health platform, introduced new tools that allow the company's clients to get more from Cerner technology, announced new predictive modeling built directly into the opioid toolkit and opened up free access to the company's training modules.

Bayer announced today that the company has signed collaboration agreements with eleven digital health startups. As part of the program, Bayer will support these startup companies aiming for longer-term collaborations to drive forward the development of specific digital solutions to improve patients' health in the fields of cardiovascular diseases, oncology, ophthalmology, pulmonology, radiology as well as digital therapeutics.

SilverCloud Health, the world's leading digital mental health company, officially announced its research collaboration with Microsoft to further enhance its online offering with artificial intelligence (AI). SilverCloud Health and Microsoft Labs in Cambridge have been working together over the past 18 months, in research that combines Microsoft's cutting-edge machine learning and

In a move to expand its Enterprise Services business, Siemens Healthineers AG, through Siemens Medical Solutions USA, Inc., has signed an agreement to acquire a majority stake in ECG Management Consultants, a leading U.S. healthcare advisory firm.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced Air Ambulance Kent Surrey Sussex (AAKSS) will equip all of its emergency service helicopters with the Philips RDT Tempus ALS [1] and Philips IntelliSpace Corsium web-based software platform.

With electronic medical records creating an ideal source of data to inform quality care and new discovery, a key question emerges: How much say should patients have in how their data is used? A new study led by Michigan Medicine researchers finds that even when patients understand the overall benefit to society, they still want to be able to give consent at least once before their de-identified data is used for research.

Roche Diagnostics is the leading provider of in vitro diagnostics. We have the ambition to continue shaping the industry by developing and providing innovative solutions for labs, payers and physicians, all for better patient health across the diagnostics continuum.